MedTrace Logo

Efficacy Study of FloSeal in Hemostasis After Laparoscopic Ovarian Cystectomy

NCT01683877 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 128

Last updated 2023-10-02

No results posted yet for this study

Summary

To compare the efficacy in postoperative hemostasis and in sparing postoperative ovarian function between FloSeal and Electrocauterization in laparoscopic ovarian cystectomy

Conditions

  • Benign Ovarian Tumor

Interventions

PROCEDURE

FloSeal application

After laparoscopic ovarian cystectomy, hemostasis will be performed using FloSeal (1 vial of FloSeal 5mL per unilateral ovarian cystectomy)

PROCEDURE

Electrocautery

After laparoscopic ovarian cystectomy, hemostasis will be performed using electrocautery

Sponsors & Collaborators

  • Baxter Healthcare Corporation

    collaborator INDUSTRY

  • Asan Medical Center

    lead OTHER

Principal Investigators

  • Joo-Hyun Nam, M.D., Ph.D. · Asan Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2016-12-31
Completion
2017-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01683877 on ClinicalTrials.gov